Grünenthal and Averitas Pharma Announce Completion of Recruitment for Phase III Clinical Trial with QUTENZA® in Post-surgical Neuropathic Pain
The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 1...
Continue Reading →
